Skip to content

Clinical trials

Recruiting Breast Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Recruiting Country / region: Spain Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20181
20191
20203
20218
20227
202319
202421
202537
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting118

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
AstraZeneca6
Eli Lilly and Company4
Hospital Universitari de Bellvitge4
Merck Sharp & Dohme LLC4
SOLTI Breast Cancer Research Group4
Daiichi Sankyo3
Novartis Pharmaceuticals3
Spanish Breast Cancer Research Group3
UNICANCER3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms118
Neoplasm Metastasis14
Ovarian Neoplasms13
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms9
Endometrial Neoplasms9
Neoplasms8
Triple Negative Breast Neoplasms8
Prostatic Neoplasms7
Stomach Neoplasms7

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.